Lunch Biot tic peptide-based apoptosis imaging agent

摘要

The present invention relates to a radiopharmaceutical imaging of apoptosis in vivo. The present invention provides an imaging agent that targets the apoptotic cells by selective binding phosphatidylethanolamine aminophospholipids are exposed on the surface of apoptotic cells to (PE). Radiopharmaceutical contains a radioactive metal complex of the chelator conjugate of PE-binding peptide. The radiopharmaceutical composition, in vivo imaging methods and kits are also provided. None [Selection Figure]